ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
686 Views
Xpeng: What Does HK IPO Mean to US Shares?
Xpeng will get listed in HK market as 9868.HK on 7th July 2021 in a fairly quick listing process. Its IPO price is announced at HK$165, equivalent...
471 Views
Xpeng Motors HK Listing - Will Probably Be Hot Given Strong Momentum but past Deal Didnāt Do Well
Xpeng Motors (XPEV US) is looking to raise about US$1.7bn via a listing in Hong Kong. We have the IPO and its previous deal. In this note, we will...
551 Views
Xpeng Secondary Listing: The Battle to Rule the Teslaverse
XPeng has launched an HKEx secondary listing to raise proceeds of $2 billion. For investors seeking exposure to the China NEV sector, XPengās...
433 Views
China Dongxiang (3818 HK): Lower-Than-Expected Dividends but Still A Marvelous FY21
China Dongxiang has delivered impressive FY21 result with good recovery in sportswear and surge in investment income. At 47% discount to book...
373 Views